Maharashtra, India

Samit Satish Mehta

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Maharashtra, IN (2016 - 2018)
  • Pune, IN (2013 - 2019)

Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Samit Satish Mehta: Innovator in Pharmaceutical Chemistry

Introduction

Samit Satish Mehta is a prominent inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 14 patents. His work focuses on innovative processes and formulations that enhance the efficacy and stability of pharmaceutical products.

Latest Patents

Among his latest patents is a process for the preparation of trientine dihydrochloride. This invention involves the reaction of protected triethylene tetramine with hydrochloric acid in an aqueous system, yielding the dihydrochloride salt while significantly controlling the formation of inorganic impurities and undesired salts. Another notable patent is for a stable liquid formulation of cabazitaxel, which comprises cabazitaxel and at least one solubilizer. This formulation is typically available in the form of ready-to-use solutions or concentrates, showcasing his commitment to improving drug delivery systems.

Career Highlights

Samit has worked with Emcure Pharmaceuticals Limited, where he has contributed to various innovative projects. His expertise in pharmaceutical formulations and processes has made him a valuable asset in the industry.

Collaborations

He has collaborated with notable professionals in the field, including Mukund Keshav Gurjar and Narendra Kumar Tripathy. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Samit Satish Mehta's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His innovative approaches continue to advance the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…